The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Article usage
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (425)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13263)
- Forensic Medicine (19)
- Gastroenterology (892)
- Genetic and Genomic Medicine (5076)
- Geriatric Medicine (471)
- Health Economics (776)
- Health Informatics (3202)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (515)
- Neurology (4829)
- Nursing (256)
- Nutrition (717)
- Oncology (2490)
- Ophthalmology (709)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1284)
- Primary Care Research (551)
- Public and Global Health (7397)
- Radiology and Imaging (1677)
- Respiratory Medicine (975)
- Rheumatology (474)
- Sports Medicine (417)
- Surgery (536)
- Toxicology (70)
- Transplantation (233)
- Urology (202)